Bio-Rad Laboratories, Inc.Class A (BIO) Stock Price

BIOStock

$390.34+25.65%52W

Market Cap$10.44B

P/E12.73x

PEG Ratio4.01

Div yield—

Beta1.07

BIO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)29.80%

Price vs S&P 500 (4W)12.28%

PEG Ratio4.01

VGM Score49.41

P/E Ratio (Annual)12.73x

P/CF (Annual)18.18x

Book Value / Share (Quarterly)$268.30

P/TBV (Annual)1.12x

Revenue Growth (3Y)-2.68%

Cash Flow / Share (Quarterly)$13.21

Price vs S&P 500 (YTD)14.04%

Gross Margin (TTM)51.86%

Net Profit Margin (TTM)8.59%

EPS (TTM)$8.25

10-Day Avg Trading Volume0.25M

EPS Excl Extra (TTM)$8.25

Revenue Growth (5Y)0.29%

EPS (Annual)$27.85

ROI (Annual)8.78%

Gross Margin (Annual)52.01%

Net Profit Margin (5Y Avg)-10.04%

Cash / Share (Quarterly)$60.53

P/E Basic Excl Extra (TTM)43.49x

Revenue Growth QoQ (YoY)-0.09%

EPS Growth (5Y)-26.09%

P/E Normalized (Annual)12.73x

ROA (Last FY)7.18%

Revenue Growth TTM (YoY)1.37%

EBITD / Share (TTM)$1.75

ROE (5Y Avg)-6.36%

Operating Margin (TTM)1.82%

Cash Flow / Share (Annual)$13.88

P/B Ratio1.35x

P/B Ratio (Quarterly)1.10x

Net Income / Employee (Annual)$102,000

EV / Revenue (TTM)4.00x

Net Interest Coverage (TTM)0.10x

ROA (TTM)2.21%

EPS Growth QoQ (YoY)18.67%

EV / EBITDA (TTM)219.96x

EPS Incl Extra (Annual)$27.85

Current Ratio (Annual)5.62x

Quick Ratio (Quarterly)2.18x

3-Month Avg Trading Volume0.36M

52-Week Price Return25.65%

EV / Free Cash Flow (Annual)27.66x

P/E Incl Extra (TTM)43.49x

Revenue / Employee (TTM)$347,600

Tangible BV / Share (Quarterly)$262.32

P/S Ratio (Annual)3.74x

Asset Turnover (Annual)0.24x

52-Week High$385.92

Operating Margin (5Y Avg)11.71%

EPS Excl Extra (Annual)$27.85

CapEx CAGR (5Y)7.73%

Tangible BV CAGR (5Y)-5.54%

26-Week Price Return41.04%

Quick Ratio (Annual)3.92x

13-Week Price Return33.14%

Total Debt / Equity (Annual)0.16x

Current Ratio (Quarterly)3.14x

Enterprise Value$10.36B

Revenue / Share Growth (5Y)2.35%

Asset Turnover (TTM)0.26x

Book Value / Share Growth (5Y)-3.46%

Revenue / Employee (Annual)$346,700

Inventory Turnover (Annual)1.65x

Pretax Margin (Annual)38.54%

Cash / Share (Annual)$57.08

3-Month Return Std Dev33.81%

Gross Margin (5Y Avg)54.44%

Net Income / Employee (TTM)$29,900

EBITDA CAGR (5Y)-37.39%

EBITDA Interim CAGR (5Y)-10.27%

ROE (Last FY)10.20%

Net Interest Coverage (Annual)0.08x

EPS Basic Excl Extra (Annual)$27.85

P/FCF (TTM)27.40x

Receivables Turnover (TTM)5.68x

EV / Free Cash Flow (TTM)29.34x

Total Debt / Equity (Quarterly)0.17x

EPS Incl Extra (TTM)$8.25

Receivables Turnover (Annual)5.66x

ROI (TTM)2.69%

P/S Ratio (TTM)3.74x

Pretax Margin (5Y Avg)-13.20%

Revenue / Share (Annual)$94.69

Tangible BV / Share (Annual)$269.70

Forward P/E40.49x

Free OCF CAGR (5Y)-4.69%

Price vs S&P 500 (52W)7.34%

P/E Ratio (TTM)43.49x

EPS Growth TTM (YoY)-29.59%

Year-to-Date Return26.00%

5-Day Price Return8.24%

EPS Normalized (Annual)$27.85

ROA (5Y Avg)-4.13%

Net Profit Margin (Annual)29.42%

Month-to-Date Return17.29%

Cash Flow / Share (TTM)$-0.16

EBITD / Share (Annual)$1.51

Operating Margin (Annual)1.59%

LT Debt / Equity (Annual)0.16x

P/CF (TTM)19.64x

ROI (5Y Avg)-4.77%

P/E Excl Extra (TTM)43.49x

LT Debt / Equity (Quarterly)0.11x

EPS Basic Excl Extra (TTM)$8.25

P/TBV (Quarterly)1.12x

P/B Ratio (Annual)1.10x

Inventory Turnover (TTM)1.58x

Pretax Margin (TTM)13.53%

Book Value / Share (Annual)$276.16

Price vs S&P 500 (13W)30.34%

Net Margin Growth (5Y)-27.79%

Beta1.07x

P/FCF (Annual)25.82x

Revenue / Share (TTM)$96.57

ROE (TTM)3.15%

52-Week Low$236.73

vGradeC

gGradeD

mGradeB

vgmGradeC

BIO Earnings Surprise History

Q2 252.61est. 1.75

Q3 252.26est. 1.93

Q4 252.51est. 2.70

Q1 261.89est. 1.99

Q2 262.62est. 1.75

BIO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.60

3.50

Industry Peers — Lab Analytical Instruments(26)

Symbol	Value Score	Growth Score	Momentum Score	Price
BIOBio-Rad Laboratories, Inc.Class A	C	D	B	$390.34
AAgilent Technologies Inc.	D	C	B	$154.77
WATWaters Corp	D	C	B	$414.44
ILMNIllumina Inc	D	D	A	$224.99
MTDMettler-Toledo International	D	C	B	$1402.25
RVTYRevvity, Inc.	C	D	B	$124.84
BIO.BBio-Rad Laboratories, Inc. Class B	C	D	B	$365.08
AVTRAvantor, Inc.	B	F	A	$14.42
BRKRBruker Corporation	D	D	B	$56.85
TXG10x Genomics, Inc. Class A Common Stock	F	D	A	$64.72
ALMRAlamar Biosciences, Inc. Common Stock	—	—	A	$33.02
CTKBCytek Biosciences, Inc. Common Stock	C	C	C	$4.58
PACBPacific Biosciences of California, Inc.	D	C	C	$1.52
MASS908 Devices Inc. Common Stock	C	C	A	$11.00
EYPTEyePoint, Inc. Common Stock	D	F	F	$5.00
PREPrenetics Global Limited Class A Ordinary Share	C	D	A	$23.25
LABStandard BioTools Inc. Common Stock	A	F	D	$0.65
QTRXQuanterix Corporation Common Stock	A	C	C	$2.79
SEERSeer, Inc. Class A Common Stock	C	D	C	$2.04
NAUTNautilus Biotechnolgy, Inc. Common Stock	—	—	C	$0.88
RPIDRapid Micro Biosystems, Inc. Class A Common Stock	C	B	D	$1.66
PRPOPrecipio, Inc. Common Stock	C	A	A	$30.85
HBIOHarvard Bioscience Inc	B	F	A	$7.58
ASTCAstrotech Corporation (DE) Common Stock	C	C	A	$7.10
BNGOBionano Genomics, Inc. Common Stock	A	C	C	$1.25
HLTHTema Healthcare AI ETF	—	F	D	$29.92
PRENWPrenetics Global Limited Warrant	—	—	D	$0.01

About Bio-Rad Laboratories, Inc.Class A

Bio-Rad Laboratories manufactures diagnostic systems, quality controls, and life sciences instruments serving clinical labs, research institutions, and biopharmaceutical producers. The company derives 60% of revenue from clinical diagnostics and 40% from life sciences (including dPCR technology leadership), with balanced geographic exposure across Americas (40%), Europe (30%), and Asia (30%). A significant 33% ownership stake in Sartorius provides strategic exposure to the growing single-use biopharmaceutical manufacturing market.